Evaluation of cellular impedance measures of cardiomyocyte cultures for drug screening applications

Assay and Drug Development Technologies

Volumn 10, Issue 6, 2012, Pages 525-532

  Peters, Matthew F ^a   Scott, Clay W ^a   Ochalski, Rafal ^a   Dragan, Yvonne P ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMOXICILLIN; ATENOLOL; BAYK 8644; BEPRIDIL; CAPTOPRIL; CARBACHOL; CARDIOVASCULAR AGENT; CHLOROQUINE; CLONIDINE; DIGOXIN; DOBUTAMINE; DOXORUBICIN; FLECAINIDE; FUROSEMIDE; HALOPERIDOL; ISOPRENALINE; LAPATINIB; MILRINONE; NIFEDIPINE; PARACETAMOL; PRAVASTATIN; QUINIDINE; TETRODOTOXIN; UNCLASSIFIED DRUG; VERAPAMIL;

ACCURACY; ACTION POTENTIAL; ANIMAL CELL; ARTICLE; BLOOD LEVEL; CARDIOMYOCYTE IMPEDANCE ASSAY; CELL ACTIVITY; CELL ASSAY; CELL DENSITY; CONTROLLED STUDY; CULTURE OPTIMIZATION; DATA ANALYSIS; DRUG POTENCY; HEART BEAT; HEART CELL CULTURE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART RATE; HIGH THROUGHPUT SCREENING; IMPEDANCE; IN VITRO STUDY; NEWBORN; NONHUMAN; RAT; SENSITIVITY ANALYSIS;

ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL ASSAY; CARDIOVASCULAR AGENTS; CELLS, CULTURED; CULTURE MEDIA; DATA INTERPRETATION, STATISTICAL; DIMETHYL SULFOXIDE; DRUG EVALUATION, PRECLINICAL; ELECTRIC IMPEDANCE; ETHER-A-GO-GO POTASSIUM CHANNELS; HEART RATE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; RATS; RATS, WISTAR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84870875516     PISSN: 1540658X     EISSN: 15578127     Source Type: Journal    
DOI: 10.1089/adt.2011.442     Document Type: Article

References (25)

1. Shah RR: Can pharmacogenetics help rescue drugs withdrawn from the market? Pharmacogenomics 2006;7:889-908.
2. Wallis RM: Integrated risk assessment and predictive value to humans of nonclinical repolarization assays. Br J Pharmacol 2010;159:115-121.
3. Gintant G: An evaluation of hERG current assay performance: translating preclinical safety studies to clinical QT prolongation. Pharmacol Ther 2011;129:109-119.
4. Laverty H, Benson C, Cartwright E, Cross M, Garland C, Hammond T, Holloway C, McMahon N, Milligan J, Park B, Pirmohamed M, Pollard C, Radford J, Roome N, Sager P, Singh S, Suter T, Suter W, Trafford A, Volders P, Wallis R, Weaver R, York M, Valentin J: How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines? Br J Pharmacol 2011;163:675-693.
5. Keese CR, Wegener J, Walker SR, Giaever I: Electrical wound-healing assay for cells in vitro. Proc Natl Acad Sci USA 2004;101:1554-1559.
6. Scott CW, Peters MF: Label-free whole-cell assays: expanding the scope of GPCR screening. Drug Discov Today 2010;15:704-716.
7. Hong J, Kandasamy K, Marimuthu M, Choi CS, Kim S: Electrical cell-substrate impedance sensing as a non-invasive tool for cancer cell study. Analyst 2011;136:237-245.
8. Rakhilin S, Turner G, Katz M, Warden R, Irelan J, Abassi YA, Glass DJ: Electrical impedance as a novel biomarker of myotube atrophy and hypertrophy. J Biomol Screen 2011;16:565-574.
9. Meissner R, Eker B, Kasi H, Bertsch A, Renaud P: Distinguishing drug-induced minor morphological changes from major cellular damage via label-free impedimetric toxicity screening. Lab Chip 2011;11:2352-2361.
10. Haas S, Jahnke HG, Glass M, Azendorf R, Schmidt S, Robitzki AA: Real-time monitoring of relaxation and contractility of smooth muscle cells on a novel biohybrid chip. Lab Chip 2010;10:2965-2971.
11. Giaever I, Keese CR: Micromotion of mammalian cells measured electrically. Proc Natl Acad Sci USA 1991;88:7896-7900.
12. Simpson P, McGrath A, Savion S: Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. Circ Res 1982;51:787-801.
13. Simpson P: Stimulation of hypertrophy of cultured neonatal rat heart cells through an alpha 1-adrenergic receptor and induction of beating through an alpha 1- and beta 1-adrenergic receptor interaction. Evidence for independent regulation of growth and beating. Circ Res 1985;56:884-894.
14. Abassi YA, Xi B, Li N, Ouyang W, Seiler A, Watzele M, Kettenhofen R, Bohlen H, Ehlich A, Kolossov E, Wang X, Xu X: Dynamic monitoring of beating periodicity of stem cell derived cardiomyocytes as a predictive tool for preclinical safety assessment. Br J Pharmacol 2012;165:1424-1441.
15. Just L, Kursten A, Borth-Bruhns T, Lindenmaier W, Rohde M, Dittmar K, Bader A: Formation of three-dimensional fetal myocardial tissue cultures from rat for long-term cultivation. Dev Dyn 2006;235:2200-2209.
16. Filtz TM, Grubb DR, McLeod-Dryden TJ, Luo J, Woodcock EA: Gq-initiated cardiomyocyte hypertrophy is mediated by phospholipase Cbeta1b. FASEB J 2009;23:3564-3570.
17. Peters MF, Knappenberger KS, Wilkins D, Sygowski LA, Lazor LA, Liu J, Scott CW: Evaluation of cellular dielectric spectroscopy, a whole-cell, label-free technology for drug discovery on Gi-coupled GPCRs. J Biomol Screen 2007;12: 312-319.
18. Guo L, Abrams RM, Babiarz JE, Cohen JD, Kameoka S, Sanders MJ, Chiao E, Kolaja KL: Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Sci 2011;123:281-289.
19. Jonsson MK, Wang QD, Becker B: Impedance-Based Detection of beating rhythm and proarrhythmic effects of compounds on stem cell-derived cardiomyocytes. Assay Drug Dev Technol 2011;9:589-599.
20. Xi B, Wang T, Li N, Ouyang W, Zhang W, Wu J, Xu X, Wang X, Abassi Y: Functional cardiotoxicity profiling and screening using the xCELLigence RTCA Cardio system. JALA 2011;16:415-421.
21. Das M, Molnar P, Gregory C, Riedel L, Jamshidi A, Hickman JJ: Long-term culture of embryonic rat cardiomyocytes on an organosilane surface in a serum-free medium. Biomaterials 2004;25:5643-5647.
22. Lunn CA: Label-free screening assays: a strategy for finding better drug candidates. Future Med Chem 2010;2:1703-1716.
23. Heyse S, Steigele S, Leven O: Its in the analysis. Drug Discov. Devel. 2011;2011:20.
24. Peters MF, Scott CW: Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity. J Biomol Screen 2009;14:246-255.
25. Abassi YA, Xi B, Zhang W, Ye P, Kirstein SL, Gaylord MR, Feinstein SC, Wang X, Xu X: Kinetic cell-based morphological screening: prediction of mechanism of compound action and off-target effects. Chem Biol 2009;16:712-723.